Status:

COMPLETED

A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects

Lead Sponsor:

Bristol-Myers Squibb

Conditions:

Healthy

Eligibility:

All Genders

18-55 years

Phase:

PHASE1

Brief Summary

The primary purpose of this study is to determine if single doses of BMS-986166 are safe and well tolerated in healthy male subjects and female subjects of non-childbearing potential.

Eligibility Criteria

Inclusion

  • For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
  • Healthy female subjects of non-childbearing potential or male subjects as determined by medical history, physical examination, vital signs, 12-lead electrocardiogram (ECG), and clinical laboratory evaluations
  • Ages 18 to 55 years
  • Female subjects must provide documentation of an acceptable method of surgical sterilization or meet the protocol criteria for menopause

Exclusion

  • Any acute or chronic medical illness judged to be clinically significant by the Investigator and/or Sponsor medical monitor
  • Any acute or chronic bacterial, fungal or viral infection, including tuberculosis, HIV, hepatitis B or hepatitis C, as defined in the protocol
  • History of heart disease, neurological disease, eye disorders or gastrointestinal disorders or surgery (including cholecystectomy)
  • Evidence of organ dysfunction or any clinically significant deviation from normal in physical examination, vital signs, ECGs or clinical laboratory tests
  • Smoking or nicotine use, drug or alcohol abuse within 6 months of starting the study
  • Other protocol defined inclusion/exclusion criteria could apply

Key Trial Info

Start Date :

July 28 2016

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 7 2017

Estimated Enrollment :

66 Patients enrolled

Trial Details

Trial ID

NCT02790125

Start Date

July 28 2016

End Date

November 7 2017

Last Update

November 24 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

PPD Development, LLC

Austin, Texas, United States, 78744

A Randomized, Double Blind Placebo-Controlled, Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BMS-986166 in Healthy Subjects | DecenTrialz